Antimicrobial susceptibility in community-acquired bacterial pneumonia in adults

East African Medical Journal

Volumn 80, Issue 4, 2003, Pages 213-217

  Kariuki, S ^a   Muyodi, J ^a   Mirza, B ^b   Mwatu, W ^c   Daniels, J J D ^c  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b Nairobi Hospital   (Kenya)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL PNEUMONIA; COMMUNICABLE DISEASE; DRUG EFFECT; HAEMOPHILUS INFLUENZAE; HUMAN; KENYA; PATHOGENICITY; PREVALENCE; STREPTOCOCCUS PNEUMONIAE;

ADULT; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; HAEMOPHILUS INFLUENZAE; HUMANS; KENYA; PNEUMONIA, BACTERIAL; PREVALENCE; STREPTOCOCCUS PNEUMONIAE;

EID: 0042384873     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Koulla-Shiro, S., Kuaban, C. and Belec, L. Acute community-acquired bacterial pneumonia in, human immunodeficiency virus (HIV) infected and non-HIV infected adult patients in Cameroon: aetiology and outcome. Tubercle. Lung. Dis. 1996; 77:47-51.
2. Mwachari, C.W., Cohen, C.R., Meier, A.S., Nganga, L.W., Kimari, J.N. and Odhiambo, J.A. Respiratory tract infection in HIV-1-infected adults in Nairobi, Kenya. Evaluation of risk factors and the World Health Organization treatment algorithm. J. AIDS. 2001; 27:365-371.
3. Scott, J.A.G., Hall, A.J., Muyodi, C. et al. Aetiology, outcome and risk factors for mortality among adults with acute pneumonia in Kenya. Lancet. 2000; 355:1225-1230.
4. Hawkes, C.A. Antibiotic resistance: a clinician's Perspective. Mil Med, 2000; 165(Suppl 2):43-45.
5. Lister, P.D. Emerging resistance problems among respiratory tract pathogens Amer. J. Manag. Care 2000; 6(8 Suppl):S409-S418.
6. Johnson, A.P., Warner, M., George, R.C. and Livermore, D.M. Activity of moxifloxacin against clinical isolates of Streptococcus pneumoniae from England and Wales. J. Antimicrob. Chemother. 2001; 47:411-415.
7. Soewignjo, S., Gessner, B.D., Sutanto, A. et al. Streptococcus pneumoniae nasopharyngeal carriage prevalence, serotype distribution, and resistance patterns among children on Lombok Island, Indonesia. Clin. Infect. Dis. 2001; 32:1039-1043.
8. Huebner, R.E., Wasas, A.D. and Klugman, K.P. Trends in antimicrobial resistance and serotype distribution of blood and cerebrospinal fluid isolates of Streptococcus pneumoniae in South Africa, 1991-1998. Int. J. Infect. Dis. 2000; 4:214-218.
9. Critchley, L.A., Thornsberry, C., Piazza, G., Yamakita, J., Barth, A., Sader, H.S. et al. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997-98. Clin. Microbiol Infect. 2000; 6:178-184.
10. Benbachir, M., Benredjeb, S., Boye, C.S. et al. Two-year surveillance of antibiotic resistance in Streptococcus pneumoniae in four African cities. Antimicrob. Agents Chemother. 2001; 45:627-629.
11. Karlowsky, J.A., Verma, G., Zhanel, G.G. and Hoban, D.J. Presence of ROB-1 beta-lactamase correlates with cefaclor resistance among recent isolates of Haemophilus influemae. J. Antimicrob. Chemother. 2000; 45:871-875.
12. Paul, J., Bates, J., Kimari, J. and Gilks, C. Serotypes and antibiotic susceptibilities of Streptococcus pneumoniae in Nairobi, Kenya, J. infect. 1996; 32:139-142.
13. Arthur, G., Nduba, V.N., Kariuki, S.M., Kimari, J., Bhatt, S.M. and Gilks, C.F Trends in bloodstream infection among human immunodeficiency virus-infected adults admitted to a hospital in Nairobi, Kenya, during the last decade. Clin. Infect. Dis. 2001; 33:248-256.
14. National Committee for Clinical Laboratory Standards. Method for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa, 2000.
15. Levine, O.S., Liu, G., Garman, R.L., Dowell, S.F., Yu, S. and Yang, Y. Haemophilus influenzae type b and Streptococcus pneumoniae as causes of pneumonia in Beijing, China. Emerg. Infect. Dis. 2000; 6:165-170.
16. Scott, J.A., Hall, A.L., Hannington, A., Edwards, R., Mwarumba, S., Lowe, B. et al. Serotype distribution and prevalence of resistance to benzylpenicillin in three representative populations of Streptococcus pneumoniae isolates from the coast of Kenya. Clin. Infect. Dis. 1998; 27:1442-1450.
17. Klugman, K.P. The clinical relevance of in-vitro resistance to penicillin, ampicillin, amoxycillin, and alternative agents, for the treatment of community acquired pneumonia caused by Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis. J. Antimicrob Chemother. 1996; 38:133-140.